WallStSmart
SER

Serina Therapeutics Inc

NYSE MKT: SER · HEALTHCARE · BIOTECHNOLOGY

$1.83
-1.08% today

Updated 2026-04-29

Market cap
$27.26M
P/E ratio
P/S ratio
209.73x
EPS (TTM)
$-1.91
Dividend yield
52W range
$1 – $8
Volume
4.0M

Serina Therapeutics Inc (SER) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$1.67M$1.40M$1.40M$1.73M$54000.00$3.46M$500000.00$3.15M$56000.00$130000.00
Revenue growth (YoY)-15.7%-0.6%+23.8%-96.9%+6316.2%-85.6%+530.6%-98.2%+132.1%
Cost of revenue$911000.00$685000.00$841000.00$998500.00$1.28M$3.80M$145000.00$90000.00$194000.00$85000.00
Gross profit$755000.00$719000.00$555000.00$729500.00$-1.23M$-333840.00$500000.00$3.06M$-138000.00$45000.00
Gross margin45.3%51.2%39.8%42.2%-2272.2%-9.6%100.0%97.1%-246.4%34.6%
R&D$7.87M$5.27M$5.35M$5.35M$3.58M$3.80M$1.57M$2.39M$7.48M$13.15M
SG&A$1.30M$1.29M$3.89M$9.62M$11.00M
Operating income$-12.74M$-8.42M$-10.45M$-12.56M$-10.41M$-1.63M$-2.27M$-3.13M$-17.05M$-24.02M
Operating margin-764.6%-599.5%-748.2%-726.8%-19272.2%-47.1%-454.1%-99.2%-30442.9%-18478.5%
EBITDA$-11.89M$-7.74M$-7.20M$-11.29M$-8.74M$-1.23M$-2.60M$5.92M$-10.49M$-24.02M
EBITDA margin-713.9%-550.9%-515.5%-653.1%-16185.2%-35.4%-521.0%187.7%-18726.8%-18478.5%
EBIT$-12.74M$-8.42M$-7.73M$-12.24M$-9.99M$-1.26M$-2.67M$5.83M$-10.68M$-24.11M
Interest expense$25000.00$12000.00$404000.00$3094.00$15878.00$558000.00$526000.00$213000.00
Income tax$-1.86M$-57000.00$-229000.00$148000.00$466000.00$3094.00$-250038.00$-8000.00
Effective tax rate10.7%0.9%3.0%-1.2%-4.5%-0.2%8.5%-0.2%0.0%0.0%
Net income$-15.49M$-6.58M$-7.50M$-12.15M$-10.87M$-1.26M$-2.68M$5.27M$-11.14M$-19.18M
Net income growth (YoY)+57.5%-14.0%-62.0%+10.6%+88.4%-112.1%+296.4%-311.4%-72.2%
Profit margin-929.9%-468.7%-537.4%-703.4%-20120.4%-36.5%-536.4%167.1%-19894.6%-14755.4%